share_log

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 12 05:29
Summary by Futu AI
Flagship Ventures Fund IV LP, an affiliate of Moderna, Inc., is set to sell 170,069 shares of Moderna's common stock, with an aggregate market value of approximately $25,227,406. The planned sale date is on 06/11/2024. These shares were originally acquired on 12/13/2010 as a pre-IPO venture stage investment from the issuer, with the acquisition being made in cash. Over the past three months, Flagship Ventures Fund IV LP has sold a total of 200,000 shares of Moderna, generating total gross proceeds of $24,040,269.
Flagship Ventures Fund IV LP, an affiliate of Moderna, Inc., is set to sell 170,069 shares of Moderna's common stock, with an aggregate market value of approximately $25,227,406. The planned sale date is on 06/11/2024. These shares were originally acquired on 12/13/2010 as a pre-IPO venture stage investment from the issuer, with the acquisition being made in cash. Over the past three months, Flagship Ventures Fund IV LP has sold a total of 200,000 shares of Moderna, generating total gross proceeds of $24,040,269.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.